MALCOLM JAN

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MALCOLM JAN's trades of United Therapeutics Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
15.87
Quantity 15,386
Value US$587,212
Transaction date
Proposed sale
Price
533.51
Quantity 45
Value US$24,008
Transaction date
Proposed sale
Price
509.20
Quantity 50
Value US$25,460
Transaction date
Proposed sale
Price
474.68
Quantity 50
Value US$23,734
Transaction date
Proposed sale
Price
474.23
Quantity 50
Value US$23,712
Transaction date
Proposed sale
Price
460.98
Quantity 50
Value US$23,049
Transaction date
Proposed sale
Price
495.01
Quantity 50
Value US$24,750
Transaction date
Sale
Price
400.29
Quantity 700 -57.4%
Value US$280,203
Transaction date
Proposed sale
Price
400.29
Quantity 700
Value US$280,203
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-10
PrS Proposed sale
15,386
15.87
US$587,212 		15,386 15.87 US$587,212
2026-07-10 2026-07-10
PlS Planned sale
56,144 +18.4%
437.39
US$400,216 		56,144 +18.4% 437.39 US$400,216
2026-03-17 2026-03-17
PlS Planned sale
79,549 +19.0%
349.78
US$3,238,906 		79,549 +19.0% 349.78 US$3,238,906
2026-03-17 2026-03-17
PrS Proposed sale
45
533.51
US$24,008 		45 533.51 US$24,008
2026-03-03 2026-03-03
PlS Planned sale
50 -22.7%
509.20
US$25,460 		50 -22.7% 509.20 US$25,460
2026-03-03 2026-03-03
PrS Proposed sale
50
509.20
US$25,460 		50 509.20 US$25,460
2026-02-17 2026-02-17
PlS Planned sale
50 -18.5%
474.68
US$23,734 		50 -18.5% 474.68 US$23,734
2026-02-17 2026-02-17
PrS Proposed sale
50
474.68
US$23,734 		50 474.68 US$23,734
2026-02-03 2026-02-03
PrS Proposed sale
50
474.23
US$23,712 		50 474.23 US$23,712
2026-02-03 2026-02-03
PlS Planned sale
50 -15.6%
474.23
US$23,712 		50 -15.6% 474.23 US$23,712
2026-01-20 2026-01-20
PrS Proposed sale
50
460.98
US$23,049 		50 460.98 US$23,049
2026-01-20 2026-01-16
PlS Planned sale
50 -13.5%
460.98
US$23,049 		50 -13.5% 460.98 US$23,049
2026-01-06 2026-01-06
PrS Proposed sale
50
495.01
US$24,750 		50 495.01 US$24,750
2026-01-06 2026-01-05
PlS Planned sale
50 -11.9%
495.01
US$24,750 		50 -11.9% 495.01 US$24,750
2025-12-23 2025-12-23
PlS Planned sale
50 -10.6%
512.12
US$25,606 		50 -10.6% 512.12 US$25,606
2025-12-12 2025-12-11
PlS Planned sale
50 -9.6%
482.98
US$24,149 		50 -9.6% 482.98 US$24,149
2025-09-10 2025-09-09
S Sale
700 -57.4%
400.29
US$280,203 		700 -57.4% 400.29 US$280,203
2025-09-09 2025-09-09
PrS Proposed sale
700
400.29
US$280,203 		700 400.29 US$280,203